Genprex Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Gene Therapy to Treat Type 1 Diabetes at 16th Annual International Conference on Advanced Technologies & Treatment for Diabetes 2023 February 23, 2023Kalyn DabbsPress Releases Results show statistically significant decreases in insulin requirements, increases in c-peptide levels and improvements in glucose tolerance compared to baseline Read More
Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh December 15, 2022Kalyn DabbsPress Releases Technology for modulating autoimmunity expands intellectual property portfolio Read More